Skip to search.
 FTSE 100 Down 0.93%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.64 Down 0.02(0.43%) 17 Apr 21:00
|After Hours: : 4.65 Up 0.01 (0.22%) 17 Apr 22:57
Add to Portfolio
Prev Close:4.66
Open:4.61
Bid:4.55 x 300
Ask:4.65 x 3000
1y Target Est:7.42
Beta:-4.46
Earnings Date:11 May - 15 May (Est.)
Day's Range:4.55 - 4.73
52wk Range:3.26 - 7.22
Volume:3,121,266
Avg Vol (3m):4,968,260
Market Cap:1.12b
P/E (ttm):N/A
EPS (ttm):-0.28
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNADown 0.43%1.12b
GSKDown 0.61%113.76b
OREXDown 3.33%932.90m
RHHBYDown 1.53%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):30.44
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.53
Quarterly EPS Est (Mar-15) :-0.14
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.43

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback